Fitness of Human Immunodeficiency Virus Type 1 Protease Inhibitor-Selected Single Mutants
- 1 September 2000
- Vol. 275 (2) , 318-322
- https://doi.org/10.1006/viro.2000.0527
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapyAIDS, 1999
- HIV-1 Drug Resistance in Newly Infected IndividualsJAMA, 1999
- Reduced Antiretroviral Drug Susceptibility Among Patients With Primary HIV InfectionJAMA, 1999
- Phenotypic Changes in Drug Susceptibility Associated with Failure of Human Immunodeficiency Virus Type 1 (HIV‐1) Triple Combination TherapyThe Journal of Infectious Diseases, 1999
- Sexual Transmission of an HIV-1 Variant Resistant to Multiple Reverse-Transcriptase and Protease InhibitorsNew England Journal of Medicine, 1998
- Antiretroviral Drug Resistance Testing in Adults With HIV InfectionJAMA, 1998
- Ordered accumulation of mutations in HIV protease confers resistance to ritonavirNature Medicine, 1996
- Extensive polymorphisms observed in HIV–1 clade B protease gene using high–density oligonucleotide arraysNature Medicine, 1996
- Kinetic Characterization and Cross-Resistance Patterns Of HIV-1 Protease Mutants Selected under Drug PressureBiochemistry, 1995
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995